| Su | Mo | Tu | We | Th | Fr | Sa |
|---|---|---|---|---|---|---|
| Su | Mo | Tu | We | Th | Fr | Sa |
|---|---|---|---|---|---|---|
-
Aug 22, 2014Generates Opportunity to Leverage Existing Vascular Technologies and Customer Relationships to Drive Increased Market Penetration
DUBLIN, Ireland--(BUSINESS WIRE)--Aug. 22, 2014-- Covidien plc (NYSE:COV) today announced it has acquired Reverse Medical Corporation, a privately held medical device company focused on expanding...
-
Aug 21, 2014
MINNEAPOLIS - August 21, 2014 - The board of directors of Medtronic, Inc. (NYSE:MDT) today approved a cash dividend of $0.305 per share of the company's common stock. The quarterly dividend...
-
Aug 21, 2014
DUBLIN, Ireland--(BUSINESS WIRE)--Aug. 21, 2014-- Covidien plc (NYSE: COV) today announced that the U.S. Food and Drug Administration (FDA) has approved changes to the manufacturing process for...
-
Aug 20, 2014Facility offers educational resources, research capabilities
SÃO PAULO--(BUSINESS WIRE)--Aug. 20, 2014-- Covidien plc (NYSE: COV) today officially opened its Covidien Center of Innovation Brazil (CCI Brazil), further expanding its educational and research...
-
Aug 20, 2014
MINNEAPOLIS - August 20, 2014 - Greater Twin Cities United Way today strengthened their long-standing commitment to improving the health and well-being of Twin Cities' communities by teaming up...
-
Aug 19, 2014Revenue of $4.3 Billion Grew 4% on Constant Currency Basis; 5% as Reported
MINNEAPOLIS - Aug. 19, 2014 - Medtronic, Inc. (NYSE: MDT) today announced financial results for its first quarter of fiscal year 2015, which ended July 25, 2014. The company reported worldwide...
-
Aug 18, 2014Largest directional atherectomy study with independent, core lab analysis demonstrates high limb salvage in patients with critical limb ischemia and strong patency rates in both diabetic and claudicant patients
DUBLIN, Ireland--(BUSINESS WIRE)--Aug. 18, 2014-- Directional atherectomy is safe and effective as a frontline therapy for the treatment of peripheral arterial disease (PAD), according to a...
-
Aug 11, 2014Distance Runners from Around the World Who Benefit from Medical Technology to Run Medtronic Twin Cities Marathon Events this Fall
MINNEAPOLIS - August 11, 2014 - Twenty-five long-distance runners who benefit from medical technology will be honored as "Medtronic Global Heroes" when they run as a team in the Medtronic Twin...
-
Aug 11, 2014
MINNEAPOLIS - Aug. 11, 2014 - Medtronic, Inc. (NYSE: MDT) announced today it will report financial results for the first quarter of its fiscal year 2015 on Tuesday, August 19, 2014. A news release...
-
Aug 7, 2014New System Helps Physicians Deliver Cardiac Resynchronization Therapy Optimally and Efficiently to Heart Failure Patients
MINNEAPOLIS - Aug. 7, 2014 - Medtronic, Inc. (NYSE: MDT) today announced it has received United States Food and Drug Administration (FDA) approval for the Attain Performa® Model 4298 quadripolar...